QurAlis pulls in $5.5 mln seed

Cambridge, Massachusetts-based QurAlis Corporation, a biotech company focused on developing precision therapeutics for ALS and other neurological diseases, has raised $5.5 million in seed funding. The investors included BioInnovation Capital, Viva Biotech Limited, MP Healthcare Venture Management and Amgen Ventures.

ManagersNorth AmericaUSHealthcareBriefs